Research Article

Sentinel Node Mapping in Ovarian Tumors: A Study Using Lymphoscintigraphy and SPECT/CT

Table 2

The published studies on ovarian sentinel node mapping.

First author/yearStudy population/number of patientsMapping materialSite of injectionWait time after injectionSLNs locationDetection rate/false negative rate

Vanneuville/1991 [15]Ablation of benign ovarian cyst or for tubal ligation/14Tc-99m + rhenium sulfide colloidMesovarium (of normal ovaries)4–6 hr scintigraphyAortic only 33%/both aortic and pelvic 67%85.7%/NA
Negishi/2004 [16]Ten endometrial cancer, one fallopian tube tumor/11CH40 (charcoal solution)Ovarian cortex10 minAortic only 64%/ both aortic and pelvic 36%100%/NA
Kleppe/2014 [17]Patients with a pelvic mass suggestive of a malignant ovarian tumor/21Tc-99m—albumin nanocolloid + blue dyeProper ovarian and suspensory ligamentMinimum 15 minAortic only 67%/ pelvic only 9.5%/ both aortic and pelvic 24%100%/0%
Hassanzadeh/2016 [11]Patients with ovarian mass (cancer = 13,benign = 1, borderline = 21 patients)/35Tc-99m-Phytate + blue dye (in only four patients)10: normal ovarian cortex 25: proper ovarian and suspensory ligament10 minAortic only 84%/ pelvic only 8%/ both aortic and pelvic 8%Cortex injection: 40%/0% ligaments injection: 84%/0%
radiotracer 71.4%/0%
Angelucci/2016 [18]Early ovarian carcinoma/5ICGHilum of the ovary2 minAortic only 40%/ pelvic only 20%/ both aortic and pelvic 40%100%/NA
Buda/2017 [19]Suspicion of malignant ovarian tumor (7 patients) + cervical carcinoma (3 patients)/10ICGDorsal and ventral side of the proper ovarian and suspensory ligamentReal timeAortic only 67%/pelvic only 11%/both aortic and pelvic 22%90%/NA
Speth/2017 [20]Three endometrial cancer G3/3Tc-99m—albumin nanocolloid + blue dyeProper ovarian and suspensory ligament15 minAortic only 67%/pelvic only 33%100%/NA
Nyberg/2017 [21]Ovarian mass (cancer = 5, benign = 11, borderline = 4 patients)/20Tc-99m—albumin nanocolloid + blue dyeMesovarium10–20 minAortic only 60%/pelvic only 10%/both aortic and pelvic 30%100%/0%
Lago/2019 [12]Early ovarian cancer/10Tc-99m—albumin colloid +IGCProper ovarian and suspensory ligament stumps15–30 minNATc-99m:100%
(IGC: 90%)/50%
Uccella/2019 [13]Early ovarian cancer/31ICGDorsal and ventral side of the proper ovarian and suspensory ligament5–20 minAortic only 62%/ pelvic only 19%/both aortic and pelvic 19%67.7%/0%
Lago/2020 [22]Early ovarian cancer/20Tc-99m—albumin colloid + IGCProper ovarian and suspensory ligament stumps15–30 minAortic only 5%/ both aortic and pelvic 95%Tc-99m:100%/NA
IGC: 95%/NA
Laven/2020 [23]Pelvic mass suspicious for malignancy (8 patients) or with a history of prior resection of a malignant ovarian mass (3 patients)/11Tc-99m—albumin nanocolloid + blue dyeDorsal and ventral sides of the remains of the proper ovarian and suspensory ligamentsAt least 15 minAortic only 18%/ both aortic and pelvic 9%Tc-99m: 27%/NA
blue dye: 0%/NA
The current studySuspicion of malignant ovarian tumor/30Tc-99m-phytateProper ovarian and suspensory ligament15–20 minAortic only 20%/pelvic only 23%/both aortic and pelvic 47%90%/NA

Eight patients were considered in this study. Of these, five cases with an ovarian tumor were published elsewhere [20]. As such, these five patients were excluded from the study in question. ICG, indocyanine green; Tc-99m, technetium 99; NA, not available; SPECT/CT, single-photon emission computed tomography/computed tomography.